findmyKOL
Clinical trialNCT00393276CompletedPhase 1Interventional

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment29HIV InfectionsHepatitis C
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Infection with either HIV or hepatitis C virus (HCV) affects immune system responses. The purpose of this study is to investigate the immune responses to two different vaccine formulations in HIV-infected, HCV-infected, and HCV/HIV- coinfected individuals.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Puerto Rico
  • Puerto Rico Aids Clinical Trials Unit Crs

    San Juan, Puerto Rico

United States
  • Ucsd Antiviral Research Center Crs

    San Diego, California, United States

  • Ucsf Aids Crs

    San Francisco, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Ihv Baltimore Treatment Crs

    Baltimore, Maryland, United States

  • Massachusetts General Hospital Clinical Research Site (mgh Crs) Crs

    Boston, Massachusetts, United States

  • Columbia P&s Crs

    New York, New York, United States

  • Duke Univ. Med. Ctr. Adult Crs

    Durham, North Carolina, United States

  • Case Crs

    Cleveland, Ohio, United States

  • Metrohealth Crs

    Cleveland, Ohio, United States

  • the Ohio State University Medical Center

    Columbus, Ohio, United States

  • Trinity Health and Wellness Center Crs

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DecavacTwinrix
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2007
Primary completion
31 Jul 2009
Completion
31 Jul 2009
Last update posted
1 Nov 2021
Registered enrollment
29
Registry id
NCT00393276
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.